PCNT and cancer: Inactivating mutations of pericentrin lead to cell cycle checkpoint and microtubule organization defects, resulting in mitotic arrest, dwarfism and ciliopathies, whereas pericentrin overexpression is seen in cancers and correlates with chromosomal instability (reviewed in [41]).